(Q24200328)

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Randomized controlled trial of ipratropium bromide and salbutamol versus salbutamol alone in children with acute exacerbation of asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Randomized controlled trial of ipratropium bromide and frequent low doses of salbutamol in the management of mild and moderate acute pediatric asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Efficacy of nebulized ipratropium in severely asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Effect of nebulized ipratropium on the hospitalization rates of children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Nebulized salbutamol vs salbutamol and ipratropium combination in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Effects of two nebulization regimens on heart rate variability during acute asthma exacerbations in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Randomized, double-blind, placebo-controlled trial of intravenous salbutamol and nebulized ipratropium bromide in early management of severe acute asthma in children presenting to an emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

The effects of ipratropium bromide and fenoterol nebulizer solutions in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Response to bronchodilators assessed by lung mechanics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Bronchodilator effects of clemastine, ipratropium, bromide, and salbutamol in preschool children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Bronchodilator effect of inhaled ipratropium bromide in wheezy toddlers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Addition of ipratropium to nebulized albuterol in children with acute asthma presenting to a pediatric office

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Nebulized salbutamol and ipratropium bromide in asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Ipratropium bromide in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Comparison of levalbuterol and racemic albuterol combined with ipratropium bromide in acute pediatric asthma: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Salbutamol and ipratropium in acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Nebulised ipratropium and salbutamol in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Benefits of ipratropium bromide in the management of asthmatic crises in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Bronchial responsiveness to hyperventilation in children with asthma: inhibition by ipratropium bromide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

An international perspective on anticholinergic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

The Pediatric Respiratory Assessment Measure: a valid clinical score for assessing acute asthma severity from toddlers to teenagers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Estimation of a common effect parameter from sparse follow-up data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Variations in pediatric pneumonia and bronchitis/asthma admission rates. Is appropriateness a factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Early emergency department treatment of acute asthma with systemic corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

The role of anticholinergic antimuscarinic bronchodilator therapy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

FEV1 performance among patients with acute asthma: results from a multicenter clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Fenoterol: a beta2-adrenergic agonist for use in asthma. Pharmacology, pharmacokinetics, clinical efficacy and adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Anticholinergic therapy for acute asthma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Combined inhaled anticholinergic agents and beta-2-agonists for initial treatment of acute asthma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

Association of population and practice factors with potentially avoidable admission rates for chronic diseases in London: cross sectional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

A place for ipratropium bromide in the treatment of severe acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

7 January 2021

Evaluation of a program for the pharmacologic management of children with asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

7 January 2021

Comparison of ipratropium solution, fenoterol solution, and their combination administered by nebulizer and face mask to children with acute asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

7 January 2021

Frequent administration by inhalation of salbutamol and ipratropium bromide in the initial management of severe acute asthma in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

7 January 2021

Use of ipratropium bromide by inhalation in the treatment of acute asthma in children. Clinical experience

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

7 January 2021

Inhaled ipratropium bromide and terbutaline in asthmatic children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

7 January 2021

Determination of dose-response reltionship for nebulized ipratropium in asthmatic children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

7 January 2021

The delivery of inhaled medication to the young child

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

7 January 2021

Comparison of nebulized ipratropium bromide with salbutamol vs salbutamol alone in acute asthma exacerbation in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

7 January 2021

The Preschool Respiratory Assessment Measure (PRAM): a responsive index of acute asthma severity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

7 January 2021

Ipratropium bromide in acute asthma.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

7 January 2021

Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

7 January 2021

Forced expiratory manoeuvres in children: do they meet ATS and ERS criteria for spirometry?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

7 January 2021

Efficacy of atropine methylnitrate alone and in combination with albuterol in children with asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

7 January 2021

Ipratropium bromide added to asthma treatment in the pediatric emergency department

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

7 January 2021

Inhaled salbutamol plus ipratropium in moderate and severe asthma crises in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000060.PUB2

7 January 2021

10.1002/14651858.CD000060.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

23966133

1 reference

Consolidated OpenCitations Corpus – April 2017